Can sensitivity to cytotoxic chemotherapy be predicted by biomarkers?

Date 29 September 2012
Event ESMO Congress 2012
Session Molecular oncology: Strategies to improve outcome in NSCLC - Repetition
Topics Lung and other Thoracic Tumours
Pathology/Molecular Biology
Presenter Enriqueta Felip
Authors E. Felip
  • Oncologia Médica, Vall d`Hebron University Hospital Institut d'Oncologia, 08035 - Barcelona/ES